AI-ACCELERATED DRUG DISCOVERY
Our platform
Technology
Drug discovery
Platforms:
Small Molecule
Peptide
Proximity Inducers
Reaxense
Pipeline
Science
Case studies
Scientific Publications
News
About us
CONTACT US
Contact us
News & Blogs
Partnership Announcement
News
Blogs
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June 12, 2025
Receptor.AI Incorporates The REAXENSE Platform to Expand Full-Stack Drug Discovery Capabilities
News
Read
News
April 9, 2025
AI vs Physics: Present and Future of PPI Structure Prediction Methods
Blogs
Read
Blogs
April 2, 2025
Receptor.AI announces research collaboration with ono Pharmaceutical
Partnership Announcement
Read
Partnership Announcement
April 1, 2025
Receptor.AI Joins the Peptide Drug Hunting Consortium
News
Read
News
February 10, 2025
Receptor.AI and Moexa Pharmaceuticals Partner to Advance AI-Powered SMAD3 Inhibitors
Partnership Announcement
Read
Partnership Announcement
November 21, 2024
The Intersection of Generative AI and Molecular Dynamics in Drug Discovery: Limitations and Opportunities
Blogs
Read
Blogs
November 8, 2024
Receptor.AI opens headquarters in boston, strengthening u.s. market presence
News
Read
News
October 24, 2024
Receptor.AI and Reaxense Inc. Present Innovative AI-Driven Focused On-Demand Libraries for Drug Discovery
Partnership Announcement
Read
Partnership Announcement
October 7, 2024
Introducing ArtiDock 2.5: NEXT-GEN Molecular Docking
News
Read
News
October 3, 2024
Presenting the LLM-driven Workflow Orchestrator
News
Read
News
September 10, 2024
Receptor.AI and Moexa Announce Research Collaboration to Discover Novel Therapeutics Targeting Protein-Protein Interactions (PPIs) for Cancer and Fibrosis Treatment
Partnership Announcement
Read
Partnership Announcement
July 31, 2024
Designing protein proximity inducers with Receptor.AI drug discovery platform
Blogs
Read
Blogs
June 11, 2024
Receptor.AI Marks Notable Presence at the ASCO and BIO International Convention 2024
Blogs
Read
Blogs
June 7, 2024
AI Drug Discovery: Not One-Size-Fits-All – Addressing Data Challenges
Blogs
Read
Blogs
March 19, 2024
Introducing ArtiDock 2.0: A New Era in AI-Driven Drug Discovery
News
Read
News
March 13, 2024
Receptor.AI will attend Bio-Europe Spring Conference 2024
News
Read
News
March 7, 2024
NVIDIA GTC Conference 2024 Presentation Announcement
News
Read
News
December 1, 2023
Exciting News from the J.P. Morgan Healthcare Conference 2024
News
Read
News
December 1, 2023
Receptor.AI Introduces ArtiDock
News
Read
News
June 18, 2023
Receptor.AI Advances Design of Selective M3 Receptor Inhibitors
Blogs
Read
Blogs
June 18, 2023
Receptor.AI Breaks New Ground with Revolutionary M3 Inhibitors
Blogs
Read
Blogs
June 8, 2023
Unlocking the Potential of Cryptic Pockets with Receptor.AI
Blogs
Read
Blogs
May 17, 2023
Advancing Drug Selectivity with Receptor.AI
News
Read
News
May 16, 2023
Redefining Precision: Introducing Receptor.AI’s 5-Level Compound Selectivity Platform
Blogs
Read
Blogs
April 14, 2023
Advancing Drug Discovery: Receptor.AI's AI-Augmented Structure-Based Prediction Methods
News
Read
News
April 14, 2023
Benchmark of the AI-augmented structure-based activity and affinity prediction methods combined by a smart consensus function
Blogs
Read
Blogs
March 31, 2023
Receptor.AI Unveils Advanced ADME-Tox Prediction Model
News
Read
News
March 31, 2023
The key for fast and efficient AI-assisted drug discovery: benchmarking the Receptor.AI ADME-Tox prediction model
Blogs
Read
Blogs
March 17, 2023
Receptor.AI will attend Bio-Europe Spring Conference 2023
News
Read
News
March 14, 2023
The rock-solid base for Receptor.AI drug discovery platform: benchmarking the drug-target interaction AI model
Blogs
Read
Blogs
March 7, 2023
Podcast: Alan Nafiiev on Membranotropic Drug Discovery and the Future of AI in Pharma
Blogs
Read
Blogs
February 7, 2023
Identification of dual-targeting Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning
Blogs
Read
Blogs
January 30, 2023
Developing bifunctional protein degraders for difficult-to-drug proteins with the Receptor.AI Platform
Blogs
Read
Blogs
January 18, 2023
Receptor.AI introduces 3DProtDTA — the next-generation drug-target interaction AI model
Blogs
Read
Blogs
January 8, 2023
Receptor.AI helps fight obesity by acting on the “sixth taste” receptors
Blogs
Read
Blogs
January 8, 2023
The lipid membranes are druggable and available for AI-based drug design
Blogs
Read
Blogs
September 23, 2022
AI meets DEL: Is this the most powerful combo in modern drug discovery?
Blogs
Read
Blogs
August 15, 2022
Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform
Blogs
Read
Blogs
August 1, 2022
Data rules it all in AI-based drug discovery
Blogs
Read
Blogs
April 20, 2022
Undruggable targets: the major challenge for modern drug discovery
Blogs
Read
Blogs
December 9, 2021
AI contributes to understanding polypharmacology with explainable ML
Blogs
Read
Blogs
November 19, 2021
The AI that speaks the language of chemical reactions natively
Blogs
Read
Blogs
September 16, 2021
AI predicts interactions of the drugs having no clue about their chemical nature
Blogs
Read
Blogs
Privacy Policy
User Agreement
.gif)
